Former Deputy Health Chief at IBM
Former IBM executive who acknowledged Watson for Oncology faces significant challenges and defended against clinical trial requirements.
Referenced in coverage
“Former IBM executive who acknowledged Watson for Oncology faces significant challenges and defended against clinical trial requirements.”